Additional Details

  • Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients

    Duke University (Site #: 71139)
    Durham NC. 27710
    View Details
  • Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepleting Chemotherapy in Patients With Autoimmune Disorders

    MD Anderson Cancer Center
    Houston TX. 77030
    View Details
  • A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)

    Research Site
    Montreal QC. H2X 0A9
    View Details
  • A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)

    Research Site
    Trois-Rivières QC. G8T 7A1
    View Details
  • A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)

    Research Site
    Ajax ON. L1S 2J5
    View Details
  • A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)

    Research Site
    Edmonton AB. T6G 2C8
    View Details
  • A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)

    Research Site
    Sherbrooke QC. J1H 5N4
    View Details
  • A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)

    Research Site
    Vancouver BC. V6Z 2K5
    View Details
  • Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease

    University of California San Francisco
    San Francisco CA. 94143
    View Details
  • Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease

    University of Michigan
    Ann Arbor MI. 48109
    View Details
  • Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease

    University of Kansas
    Kansas City KS. 66103
    View Details
  • Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease

    University of Colorado Denver
    Aurora CO. 80045
    View Details
  • DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

    Oklahoma Heart Institute
    Tulsa OK. 74104
    View Details
  • DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

    East Carolina University Health
    Greenville NC. 27834
    View Details
  • DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

    Ohio State Richard M. Ross Heart Hospital
    Columbus OH. 43210
    View Details
  • DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

    University of Cincinnati Medical Center
    Cincinnati OH. 45219
    View Details
  • DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

    Wakemed Health and Hospital
    Raleigh NC. 27610-1231
    View Details
  • DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

    University of Maryland Medical Center
    Baltimore MD. 21201
    View Details
  • DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

    Intermountain Medical Center
    Murray UT. 84157
    View Details
  • DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

    Temple Lung Center
    Philadelphia PA. 19140
    View Details